Latest JUPITER trial Stories

2010-04-27 01:00:00

LONDON, April 27 /PRNewswire/ -- CRESTOR(TM) (rosuvastatin) has been approved in nineteen countries within the EU for the prevention of major cardiovascular events in patients who are at high risk* of having a first cardiovascular event.

2010-04-20 09:51:00

Same gene involved in statins lowering cholesterol ANN ARBOR, Mich., April 20 /PRNewswire-USNewswire/ -- A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds. The researchers had previously shown that statins - which 25 million people worldwide take each day to reduce their risk of...

2010-01-07 18:56:57

Gene variants associated with increased circulating levels of C-reactive protein, a marker of inflammation, are not associated with an increased risk of cancer.

2009-12-15 16:58:00

WILMINGTON, Del., Dec. 15 /PRNewswire-FirstCall/ -- The U.S.

2009-11-16 07:00:00

Study highlights: - Risks of an anemia drug appear to outweigh its benefits among diabetic patients with kidney disease, anemia and a history of cardiovascular disease or stroke. - This first large, randomized, placebo-controlled trial finds drug raises hemoglobin levels and reverses anemia but does not improve patient cardiovascular outcomes. - Treatment with darbepoetin alfa in patients with type 2 diabetes, chronic kidney disease and moderate anemia doubled the risk of stroke compared to...

2009-11-04 09:54:51

Searching for a needle in a haystack may seem futile, but it's worth it if the needle is a hard-to-detect protein that may identify a person at high risk of a heart attack circulating within a haystack of human serum (liquid component of blood).

2009-10-19 17:49:51

People with high levels of a protein called C-reactive protein (CRP), a marker for inflammation in the blood, may be at higher risk for heart attack and death but not stroke, according to a study published in the October 20, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

2009-07-08 15:58:00

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- The results of a study published in the current issue of the peer reviewed British Medical Journal (BMJ) support the findings of a white paper released last month by the Senior Center for Health and Security (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs known as statins. The report concluded, "In patients without established cardiovascular disease but with cardiovascular risk factors, statin use was...

2009-07-08 08:00:00

WALTHAM, Mass., July 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the treatment of dyslipidemia patients who fail to reach LDL goal, surveyed physicians are increasingly switching patients to a more potent statin --- most notably AstraZeneca's Crestor --- rather than adding Merck/Schering-Plough's Zetia (ezetimibe) or switching to Merck/Schering-Plough's Vytorin (simvastatin/ezetimibe).

2009-06-30 12:25:26

A non-profit senior health organization says the use of statins might significantly reduce the impact of cardiovascular disease in the United States. The Senior Center for Health and Security has released a white paper saying the adverse health and financial impact of cardiovascular disease -- the number one killer of men and women in the United States -- can be significantly reduced through the well monitored use of statins. The paper explores the ramifications of heart disease and stroke,...

Word of the Day
  • To say in too many words; to express verbosely.
  • To express in too many words: sometimes used reflexively.
  • The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.
The word 'overword' comes from over- +‎ word.